J&J's Suponcic decamps for Kantar

Share this article:
Kantar Health said it hired Susan Suponcic, PhD, as SVP of global market access. In her new role, Suponcic will lead a global team assisting pharma clients in incorporating, substantiating and implementing market access initiatives, according to a company statement.
Suponcic has more than 13 years of market access experience in both industry and consulting. She joins Kantar Health from Johnson & Johnson (J&J), where she held strategic roles in both pricing and health economics, led teams that carried out global launches and helped shape the external environment to focus on the value of pharmaceutical innovation, Kantar said.
Prior to J&J, Suponcic worked on the consulting side, leading IMS Health's pharma pricing consulting practice.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...